The Newborn Screening Market is projected to reach $2.49 billion by 2030, at a CAGR of 7.9% from 2023 to 2030. Newborn screening is performed for the early identification of the conditions that can affect the child’s survival or long-term health. The screening technology specifies a series of essential tests for early detection, health management, timely diagnosis, management, and prevention of disabilities in newborns.